United States' NRT Smoking Cessation Aids Industry, 2019-2029: Market Size, Company Shares, Brand Shares, And Distribution Data For Gum, Inhalators, Lozenges, Patches, And Other Aids


(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "NRT Smoking Cessation AIDS in the US" report has been added to ResearchAndMarkets.com's offering.
In 2024, NRT smoking cessation aids is set to experience low positive retail current value growth in the US. While no category is expected to achieve significant success, NRT gum is the only one projected to report positive current value growth, with NRT lozenges and patches set to decline.
The report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?

  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered
KEY DATA FINDINGS
2024 DEVELOPMENTS

  • Patch format continues to witness a stagnant performance
  • Haleon's international divestments hint at uncertain trajectory for the domestic landscape
  • More direct-to-consumer brands on the horizon

PROSPECTS AND OPPORTUNITIES

  • Nicotine cessation medication: Potential category disruptor?
  • Uncertain regulatory landscape for ZYN nicotine pouches could benefit traditional NRT solutions
  • Vaping and usage of nicotine pouches increasing amongst younger generations in the US

CATEGORY INDICATORS

  • Table 1 Number of Smokers by Gender 2019-2024

CATEGORY DATA

  • Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
  • Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
  • Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
  • Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
  • Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
  • Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029

CONSUMER HEALTH IN THE US
EXECUTIVE SUMMARY

  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS

  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 9 Life Expectancy at Birth 2019-2024

MARKET DATA

  • Table 10 Sales of Consumer Health by Category: Value 2019-2024
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 12 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029

APPENDIX

  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN02102024004107003653ID1108739711


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Newsletter